• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在囊性纤维化肺部:唑类疗法的利弊

in the cystic fibrosis lung: pros and cons of azole therapy.

作者信息

Burgel Pierre-Régis, Paugam André, Hubert Dominique, Martin Clémence

机构信息

Department of Respiratory Medicine, Cochin Hospital, Assistance Publique - Hôpitaux de Paris; Université Paris Descartes, Sorbonne Paris Cité.

Université Paris Descartes, Sorbonne Paris Cité; Parasitology-Mycology Laboratory, Cochin Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

出版信息

Infect Drug Resist. 2016 Sep 20;9:229-238. doi: 10.2147/IDR.S63621. eCollection 2016.

DOI:10.2147/IDR.S63621
PMID:27703383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5036609/
Abstract

is the main fungus cultured in the airways of patients with cystic fibrosis (CF). Allergic bronchopulmonary aspergillosis occurs in ~10% of CF patients and is clearly associated with airway damage and lung function decline. The effects of colonization in the absence of allergic bronchopulmonary aspergillosis are less well established. Retrospective clinical studies found associations of -positive cultures with computed tomography scan abnormalities, greater risk of CF exacerbations and hospitalizations, and/or lung function decline. These findings were somewhat variable among studies and provided only circumstantial evidence for a role of colonization in CF lung disease progression. The availability of a growing number of oral antifungal triazole drugs, together with the results of nonrandomized case series suggesting positive effects of azole therapies, makes it tempting to treat CF patients with these antifungal drugs. However, the only randomized controlled trial that has used itraconazole in CF patients showed no significant benefit. Because triazoles may have significant adverse effects and drug interactions, and because their prolonged use has been associated with the emergence of azole-resistant isolates, it remains unclear whether or not CF patients benefit from azole therapy.

摘要

是囊性纤维化(CF)患者气道中培养出的主要真菌。变应性支气管肺曲霉病发生在约10%的CF患者中,且与气道损伤和肺功能下降明显相关。在无变应性支气管肺曲霉病的情况下,其定植的影响尚不明确。回顾性临床研究发现,阳性培养结果与计算机断层扫描异常、CF病情加重和住院风险增加以及/或肺功能下降有关。这些研究结果在不同研究中有所差异,仅提供了曲霉定植在CF肺部疾病进展中起作用的间接证据。越来越多的口服抗真菌三唑类药物可供使用,以及非随机病例系列结果表明唑类疗法有积极作用,这使得人们倾向于用这些抗真菌药物治疗CF患者。然而,唯一一项在CF患者中使用伊曲康唑的随机对照试验未显示出显著益处。由于三唑类可能有显著的不良反应和药物相互作用,且其长期使用与唑类耐药曲霉分离株的出现有关,CF患者是否能从唑类治疗中获益仍不清楚。

相似文献

1
in the cystic fibrosis lung: pros and cons of azole therapy.在囊性纤维化肺部:唑类疗法的利弊
Infect Drug Resist. 2016 Sep 20;9:229-238. doi: 10.2147/IDR.S63621. eCollection 2016.
2
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
3
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.烟曲霉中三唑类耐药现象普遍存在,尤其是由 TR/L98H 介导的三唑类耐药现象,在法国囊性纤维化患者队列中尤为明显。
J Antimicrob Chemother. 2012 Aug;67(8):1870-3. doi: 10.1093/jac/dks160. Epub 2012 May 11.
4
Fungal infection of cystic fibrosis patients - single center experience.囊性纤维化患者的真菌感染——单中心经验
Pneumonol Alergol Pol. 2016;84(3):151-9. doi: 10.5603/PiAP.2016.0017.
5
Azoles for allergic bronchopulmonary aspergillosis associated with asthma.用于治疗与哮喘相关的变应性支气管肺曲霉病的唑类药物。
Cochrane Database Syst Rev. 2003(3):CD001108. doi: 10.1002/14651858.CD001108.
6
Azoles for allergic bronchopulmonary aspergillosis associated with asthma.用于治疗与哮喘相关的变应性支气管肺曲霉病的唑类药物。
Cochrane Database Syst Rev. 2004;2004(3):CD001108. doi: 10.1002/14651858.CD001108.pub2.
7
Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?烟曲霉唑类耐药性在囊性纤维化患者中的研究进展:值得关注吗?
Mycopathologia. 2018 Feb;183(1):151-160. doi: 10.1007/s11046-017-0162-4. Epub 2017 Jun 26.
8
Aspergillus fumigatus In-Host HOG Pathway Mutation for Cystic Fibrosis Lung Microenvironment Persistence.烟曲霉宿主 Hog 途径突变与囊性纤维化肺部微环境持续存在。
mBio. 2021 Aug 31;12(4):e0215321. doi: 10.1128/mBio.02153-21.
9
Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.烟曲霉定植于慢性囊性纤维化患者接受唑类治疗后分离株对五种抗真菌药物的敏感性。
Int J Antimicrob Agents. 2010 Apr;35(4):396-9. doi: 10.1016/j.ijantimicag.2009.12.007. Epub 2010 Feb 9.
10
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.烟曲霉所致伏立康唑高度耐药性曲霉菌感染及耐药相关分离株在家庭环境中的重现。
Clin Infect Dis. 2013 Aug;57(4):513-20. doi: 10.1093/cid/cit320. Epub 2013 May 10.

引用本文的文献

1
Highly Effective Modulator Therapy: Implications for the Microbial Landscape in Cystic Fibrosis.高效调制治疗:对囊性纤维化微生物景观的影响。
Int J Mol Sci. 2024 Nov 5;25(22):11865. doi: 10.3390/ijms252211865.
2
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces in Cystic Fibrosis.依列卡福妥/替扎卡福妥/依伐卡托显著降低囊性纤维化患者的(相关指标,原文未明确具体所指)。
Am J Respir Crit Care Med. 2024 Nov 1;210(9):1155-1158. doi: 10.1164/rccm.202406-1128RL.
3
Cystic fibrosis.囊性纤维化。
Nat Rev Dis Primers. 2024 Aug 8;10(1):53. doi: 10.1038/s41572-024-00538-6.
4
Insights into Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments.囊性纤维化中的定植以及患者与医院环境之间交叉传播的见解
J Fungi (Basel). 2024 Jun 29;10(7):461. doi: 10.3390/jof10070461.
5
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study.双重物种神经鞘氨醇-1-磷酸裂解酶抑制剂联合抗真菌和抗炎活性治疗囊性纤维化:一项可行性研究。
Sci Rep. 2023 Dec 20;13(1):22692. doi: 10.1038/s41598-023-50121-4.
6
Protective role of CFTR during fungal infection of cystic fibrosis bronchial epithelial cells with .CFTR 在囊性纤维化支气管上皮细胞真菌感染中的保护作用。
Front Cell Infect Microbiol. 2023 Aug 23;13:1196581. doi: 10.3389/fcimb.2023.1196581. eCollection 2023.
7
Pathogenicity and virulence of . 的致病性和毒力。
Virulence. 2023 Dec;14(1):2172264. doi: 10.1080/21505594.2023.2172264.
8
Suppression of Germination by Neutrophils Is Enhanced by Endothelial-Derived CSF3 Production.内皮细胞源性CSF3的产生增强了中性粒细胞对发芽的抑制作用。
Front Microbiol. 2022 Apr 29;13:837776. doi: 10.3389/fmicb.2022.837776. eCollection 2022.
9
Exposure to the secretome alters the proteome and secondary metabolite production of .暴露于外泌体改变了 的蛋白质组和次生代谢产物的产生。
Microbiology (Reading). 2022 Mar;168(3). doi: 10.1099/mic.0.001164.
10
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?囊性纤维化患者相关肺部疾病:影像学检查有助于诊断疾病吗?
Eur Respir Rev. 2021 Nov 17;30(162). doi: 10.1183/16000617.0103-2021. Print 2021 Dec 31.

本文引用的文献

1
Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis.囊性纤维化患者中曲霉菌致敏和变应性支气管肺曲霉菌病的患病率:系统评价和荟萃分析
Clin Exp Allergy. 2015 Dec;45(12):1765-78. doi: 10.1111/cea.12595.
2
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.烟曲霉唑类耐药性的前瞻性多中心国际监测。
Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.
3
Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.先前在体外接触伏立康唑会导致烟曲霉生物膜对两性霉素 B 产生耐药性。
Int J Antimicrob Agents. 2015 Sep;46(3):342-5. doi: 10.1016/j.ijantimicag.2015.03.006. Epub 2015 Apr 24.
4
The innate immune response to Aspergillus fumigatus at the alveolar surface.曲霉在肺泡表面的固有免疫反应。
FEMS Microbiol Rev. 2015 Sep;39(5):670-87. doi: 10.1093/femsre/fuv018. Epub 2015 Apr 30.
5
First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.法国首次报道因TR46/Y121F/T289A突变导致的耐唑类烟曲霉。
Antimicrob Agents Chemother. 2015 Jul;59(7):4331-5. doi: 10.1128/AAC.00127-15. Epub 2015 Apr 27.
6
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.澳大利亚出现对多种三唑类耐药的烟曲霉感染。
Mycoses. 2015 Jun;58(6):350-5. doi: 10.1111/myc.12324. Epub 2015 Apr 17.
7
Future trends in cystic fibrosis demography in 34 European countries.34 个欧洲国家囊性纤维化人口统计学的未来趋势。
Eur Respir J. 2015 Jul;46(1):133-41. doi: 10.1183/09031936.00196314. Epub 2015 Mar 18.
8
The lung mycobiome: an emerging field of the human respiratory microbiome.肺部真菌组:人类呼吸道微生物组的一个新兴领域。
Front Microbiol. 2015 Feb 13;6:89. doi: 10.3389/fmicb.2015.00089. eCollection 2015.
9
Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines.铜绿假单胞菌通过吩嗪类物质调控其微生物群伙伴烟曲霉的氧化还原和铁稳态。
Sci Rep. 2015 Feb 10;5:8220. doi: 10.1038/srep08220.
10
Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk.囊性纤维化患者住所中霉菌暴露情况及变应性支气管肺风险评估。
J Cyst Fibros. 2015 Mar;14(2):242-7. doi: 10.1016/j.jcf.2015.01.003. Epub 2015 Jan 20.